(Q33809969)

29 July 2017

1 reference

title

Clinical and economic considerations of empirical antibacterial therapy of febrile neutropenia in cancer (English)

1 reference

29 July 2017

1

Dranitsaris G

1 reference

29 July 2017

language of work or name

1 reference

1 October 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

16

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

343-353

1 reference

Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).

29 July 2017

cites work

1 reference

12 December 2020

Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer

1 reference

12 December 2020

Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group

1 reference

12 December 2020

A randomized trial of the effects of pharmacist intervention on the cost of antiemetic therapy with ondansetron.

1 reference

12 December 2020

Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving taxol

1 reference

12 December 2020

Vancomycin control measures at a tertiary-care hospital: impact of interventions on volume and patterns of use.

1 reference

12 December 2020

Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer

1 reference

12 December 2020

Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients

1 reference

12 December 2020

Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule

1 reference

12 December 2020

G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluation

1 reference

12 December 2020

Cost-benefit analysis of prophylactic granulocyte colony-stimulating factor during CHOP antineoplastic therapy for non-Hodgkin's lymphoma

1 reference

12 December 2020

Beta-lactam regimens for the febrile neutropenic patient

1 reference

12 December 2020

Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Canc

1 reference

12 December 2020

Antibiotic treatment of febrile episodes in neutropenic cancer patients. Clinical and economic considerations

1 reference

12 December 2020

Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients

1 reference

12 December 2020

Beta-lactam antibiotics alone or in combination with gentamicin for therapy of gram-negative bacillary infections in neutropenic patients

1 reference

12 December 2020

Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia.

1 reference

12 December 2020

Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived in cancer patients with fever and neutropenia

1 reference

12 December 2020

Empirical therapy for bacterial infections in neutropenic patients

1 reference

12 December 2020

Is it time to redefine the management of febrile neutropenia in cancer patients?

1 reference

12 December 2020

Pharmacoeconomic analysis of empirical therapy with ceftazidime alone or combination antibiotics for febrile neutropenia in cancer patients

1 reference

12 December 2020

Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer

1 reference

12 December 2020

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

12 December 2020

Management of fever in patients with cancer and treatment-induced neutropenia

1 reference

12 December 2020

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

1 reference

12 December 2020

Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapy

1 reference

12 December 2020

Incidence of antibiotic resistance in blood and urine isolates from hospitalized patients. Report from a European collaborative study. European Study Group on Antibiotic Resistance (ESGAR).

1 reference

12 December 2020

Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. The Meropenem Study Group of Leuven, London and Nijmegen

1 reference

12 December 2020

Antibiotic resistance in streptococci and enterococci. Where are we, where are we going? An opening lecture

1 reference

12 December 2020

Beta-lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy

1 reference

12 December 2020

Empirical treatment of febrile neutropenia: evolution of current therapeutic approaches

1 reference

12 December 2020

Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group

1 reference

12 December 2020

Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin

1 reference

12 December 2020

Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem

1 reference

12 December 2020

Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients

1 reference

12 December 2020

Piperacillin/tazobactam versus cefepime as initial empirical antimicrobial therapy in febrile neutropenic patients: a prospective randomized pilot study.

1 reference

12 December 2020

Economic analysis of prophylactic G-CSF after mini-BEAM salvage chemotherapy for Hodgkin's and non-Hodgkin's lymphoma

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor as adjunct therapy in relapsed lymphoid malignancy: implications for economic analyses of phase III clinical trials.

1 reference

12 December 2020

A randomised dosage study of ceftazidime with single daily tobramycin for the empirical management of febrile neutropenia in patients with hematological diseases

1 reference

12 December 2020

Treatment of neutropenic infection: trends towards monotherapy?

1 reference

12 December 2020

Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants.

1 reference

12 December 2020

The contribution of antibiotic use on the frequency of antibiotic resistance in hospitals.

1 reference

12 December 2020

Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia

1 reference

12 December 2020

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

12 December 2020

Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia

1 reference

12 December 2020

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule

1 reference

12 December 2020

Antibiotic therapy for the febrile granulocytopenic cancer patient: combination therapy vs. monotherapy.

1 reference

12 December 2020

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

1 reference

12 December 2020

Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia

1 reference

12 December 2020

Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies

1 reference

12 December 2020

Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial

1 reference

12 December 2020

10.2165/00019053-199916040-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

1022369700

0 references

1 reference